Clin2
NCT07749261Possibly a fitNot yet recruiting

Gut microbiome and tryptophan in Parkinson's disease

PARKINSON DISEASE (Disorder)

Part of Brain & nervous system clinical trials.

This study looks at the gut bacteria and a chemical called tryptophan (found in some foods) in people with Parkinson's disease compared with healthy people. It may help explain how the gut relates to Parkinson's symptoms. Participants will be asked to provide a stool sample.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
45 years to 90 years
Study type
Observational

Who can take part

  • You must be between 45 and 90 years old
  • You must be able to provide a stool sample
  • If you have Parkinson's, you need a diagnosis from a neurologist and be on stable Parkinson's medication for at least 4 weeks
  • If you don't have Parkinson's, you must be generally healthy with no history of Parkinson's or similar brain conditions
  • You must not have taken antibiotics in the last 3 months or certain supplements (like probiotics or tryptophan) in the last 4 weeks
  • You must not have an active infection, digestive disease, cancer, or other serious health conditions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07786116Recruiting
Gut bacteria in Parkinson's disease and related conditions

This study looks at how certain gut bacteria (methanogens) are involved in the progression of Parkinson's disease and related conditions. It aims to understand the connection between gut health and brain health, which may lead to better treatments.

Cambridge, CB2
NCT07604883Not yet recruiting
Studying gut bacteria in early parkinson's disease

This study looks at whether bacteria in the gut are different in people with early Parkinson's disease. It may help us understand the disease better and find new ways to treat it.

Warsaw
NCT07567794Recruiting
Gut-Brain Connection Study in Parkinson's Disease

This research examines how the gut and brain are connected in Parkinson's disease and aims to better understand the disease. You'd participate in visits and tests over three years, including some involving your digestive system.

Stanford, California
NCT05568498Recruiting· Phase 2
Probiotic trial for depression in Parkinson’s disease

This Phase 2 study tests whether taking probiotics can improve depression and mood symptoms in people with Parkinson’s disease. It’s meant for those with mild to moderate depression and stable Parkinson’s and mood treatments.

Vancouver, British Columbia
NCT06705517Recruiting
Mediterranean diet study for Parkinson's disease

This trial tests whether a Mediterranean diet can help people with Parkinson's disease. You would either follow your usual diet or switch to a Mediterranean diet for six months and provide blood and stool samples.

Varese, Varese
NCT07418658Not yet recruiting
Gut health study in people with untreated Parkinson's

This study looks at the gut and intestinal lining in people with Parkinson's who have not yet started treatment, compared with healthy people. It may help us understand how the gut relates to Parkinson's and could lead to better treatments.

Leuven, Vlaams-Brabant

Hear when a new PARKINSON DISEASE (Disorder) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.